No Difference in the Phenotypic Expression of Frailty among Elderly Patients Recently Diagnosed with Cancer Vs Cancer Free Patients.


Journal

The journal of nutrition, health & aging
ISSN: 1760-4788
Titre abrégé: J Nutr Health Aging
Pays: France
ID NLM: 100893366

Informations de publication

Date de publication:
2020
Historique:
entrez: 1 2 2020
pubmed: 1 2 2020
medline: 7 8 2020
Statut: ppublish

Résumé

To examine frailty determinants differences in patients with a recent diagnosis of cancer compared to non-cancer patients among older adult. Revealing those differences will allow us to individualize the exact frailty management in those patients diagnosed with cancer. This is an observational cross-sectional, monocentric study. Patients were evaluated at the Geriatric Frailty Clinic (GFC), in the Toulouse University Hospital, France, between October 2011 and February 2016. 1996 patients aged 65 and older were included (1578 patients without cancer and 418 patients with solid and hematological cancer recently diagnosed). Frailty was established according to the frailty phenotype. The frailty phenotype measures five components of frailty: weight loss, exhaustion, low physical activity, weakness and slow gait. Frailty phenotype was categorized as robust, pre-frail and frail. In a multinomial logistic regression, cancer, compared to the non-cancer group, is not associated with an increased likelihood of being classified as pre frail (RRR 0.9, 95% CI [0.5 ; 1.6 ], p 0.9) or frail (RRR 1.2, 95% CI [0.7 ; 2.0], p 0.4) rather than robust. When considering each Fried criterion, a significant higher odd of weight loss was observed in older patients with cancer compared to the non-cancer patients (OR 2.3, 95% CI [1.8; 3.0], p <0.001) but no statistically significant differences was found among the four other Fried criteria. Sensitivity analysis on the frailty index showed that cancer was not associated with a higher FI score compared to non-cancer (β 0.002, 95%CI [-0.009; 0.01], p 0.6). In this real-life study evaluating elderly patients with and without cancer, we didn't confirm our hypothesis, in fact we found that cancer was not associated with frailty severity using both a phenotypic model and a deficit accumulation approach. Cancer may contribute, at least additively, to the development of frailty, like any other comorbidity, rather than a global underlying condition of vulnerability.

Identifiants

pubmed: 32003403
doi: 10.1007/s12603-019-1293-8
pmc: PMC6989642
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

147-151

Déclaration de conflit d'intérêts

All authors declare no conflict of interest

Références

J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Palliat Med. 2019 Mar;33(3):312-322
pubmed: 30712456
JAMA. 1963 Sep 21;185:914-9
pubmed: 14044222
J Gerontol A Biol Sci Med Sci. 2004 Mar;59(3):255-63
pubmed: 15031310
Ann Oncol. 2015 Jun;26(6):1091-101
pubmed: 25403592
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Eur J Oncol Nurs. 2005;9 Suppl 2:S51-63
pubmed: 16437758
Int J Epidemiol. 2001 Dec;30(6):1371-8
pubmed: 11821349
J Gerontol A Biol Sci Med Sci. 2013 Dec;68(12):1505-11
pubmed: 23640761
J Am Geriatr Soc. 2004 Apr;52(4):625-34
pubmed: 15066083
J Gerontol A Biol Sci Med Sci. 2001 Mar;56(3):M146-56
pubmed: 11253156
J Nutr Health Aging. 2014 May;18(5):457-64
pubmed: 24886728
Lancet Oncol. 2012 Oct;13(10):e437-44
pubmed: 23026829
Clin Geriatr Med. 2011 Feb;27(1):17-26
pubmed: 21093719
J Gerontol. 1994 Mar;49(2):M85-94
pubmed: 8126356
Nestle Nutr Workshop Ser Clin Perform Programme. 1999;1:3-11; discussion 11-2
pubmed: 11490593
J Gerontol A Biol Sci Med Sci. 2007 Jul;62(7):722-7
pubmed: 17634318
Acta Oncol. 2016 May;55(5):644-6
pubmed: 26471475
JAMA Intern Med. 2016 Jun 1;176(6):816-25
pubmed: 27183032
Nephrol Dial Transplant. 2008 Jan;23(1):47-51
pubmed: 17890752
Curr Osteoporos Rep. 2017 Apr;15(2):76-87
pubmed: 28497213
Support Care Cancer. 2019 Jul;27(7):2747-2753
pubmed: 30903367

Auteurs

K El Haddad (K)

K. EL Haddad, Institut du Vieillissement, Gérontopôle, Université Toulouse III Paul Sabatier, 37 Allées Jules Guesde, 31000 Toulouse, France. E-mail: kamal.elhaddad@hotmail.com, Tel: +33561145657; fax: +33561145640.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH